M&A Deal Summary |
|
|---|---|
| Date | 2025-12-09 |
| Target | Teleflex Medical OEM |
| Sector | Medical Products |
| Buyer(s) |
Montagu
Kohlberg & Company |
| Sellers(s) | Teleflex |
| Deal Type | Divestiture |
| Deal Value | 1.5B USD |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1968 |
| PE ASSETS | 11.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Montagu is an independent private equity firm focused on European management buyouts and growth capital transactions. The Firm seeks opportunities valued between €100 million and €1 billion. Sectors of interest include healthcare, medical products, financial services, software, IT, information services, and education. Montagu dates back to 1968 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 119 of 119 |
| Sector: Medical Products M&A | 12 of 12 |
| Type: Divestiture M&A Deals | 24 of 24 |
| State: Minnesota M&A | 1 of 1 |
| Country: United States M&A | 7 of 7 |
| Year: 2025 M&A | 4 of 4 |
| Size (of disclosed) | 3 of 32 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-07-25 |
IAI Group
Poland IAI Group is a digital retail solutions provider, enabling mid-to-large-sized merchants in Poland and Central and Eastern Europe to build thriving e-commerce operations. The Company’s flagship product, IdoSell, is a comprehensive proprietary technology platform that powers individual merchants’ end-to-end online operations – from consumer-facing storefronts to value-added services including marketing, logistics, and payments. IAI was founded in 2000 and is based in Poland. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Kohlberg & Company is a private equity firm which acquires middle-market companies with consistent cash flow, and underperforming companies with operational deficiencies. Kohlberg looks to commit $100 to $500 million of equity capital in opportunities valued from $200 million to $2 billion. Kohlberg generally looks for opportunities in the manufacturing and service sectors, however the Firm will also selectively consider businesses in food and healthcare. Kohlberg tends not to consider technology or communications companies. Kohlberg & Company was formed in 1987 and has offices in Mt. Kisco, New York.
| DEAL STATS | # |
|---|---|
| Overall | 82 of 82 |
| Sector: Medical Products M&A | 5 of 5 |
| Type: Divestiture M&A Deals | 11 of 11 |
| State: Minnesota M&A | 2 of 2 |
| Country: United States M&A | 81 of 81 |
| Year: 2025 M&A | 2 of 2 |
| Size (of disclosed) | 1 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-04-29 |
RESA Power
Houston, Texas, United States RESA Power provides mission-critical electrical system services and products for industrial, commercial, institutional, government, and utility end-users across North America. It provides quick turn-around custom manufactured or retrofit switchgear & breaker solutions and maintains an extensive inventory of obsolete and hard-to-find components. RESA Power was founded in 1928 and is based in Houston, Texas. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1943 |
| Sector | Medical Products |
| Employees | 14,100 |
| Revenue | 3.0B USD (2024) |
Teleflex is a provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Teleflex markets and sells its products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Teleflex was founded in 1943 and is based in Wayne, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 10 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 10 of 10 |
| State: Minnesota M&A | 1 of 1 |
| Country: United States M&A | 8 of 8 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-02-27 |
Biotronik s Vascular Intervention Business
Berlin, Germany Biotronik's Vascular Intervention Business consists of a comprehensive and differentiated portfolio for coronary and peripheral interventions performed in the cath lab and interventional radiology suites. In coronary vascular interventions, key products include the Pantera Lux Drug-Coated Balloon Catheter, the novel PK Papyrus Covered Coronary Stent for acute coronary artery perforations, and the Orsiro Mission Drug Eluting Stent, an ultrathin drug-eluting stent with differentiated clinical features. |
Buy | €760M |
